Biotechnology

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS

Opthea Limited released FY2026 Semi-Annual Earnings on March 1 (EST), with actual revenue of USD 665.54K and EPS of USD 1.36

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2026 Q1 earnings on March 1, 2026 (EST), with actual revenue of USD 500 and EPS of USD 1.0208

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2026 Q2 earnings on March 1, 2026 (EST) with actual revenue of USD 334.74K and actual EPS of USD 0.6834

Opthea Limited released FY2025 Q4 earnings on September 15, 2025 (EST), with actual revenue of USD -1.5 K and EPS of USD -0.1003.

Opthea Limited released FY2024 9 Months Earnings on September 15, 2025 (EST) with actual revenue of USD 232K and EPS of USD -2.0671

Opthea Limited released FY2025 Q3 earnings on September 15 (EST) with actual revenue of USD -1.5K and EPS of USD -0.1003

Opthea Limited released FY2024 Q4 earnings on September 15, 2025 (EST) with actual revenue of USD 30K and EPS of USD -0.6927

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2024 Q3 earnings on September 15, 2025 (EST), actual revenue USD 30K, actual EPS USD -0.6927

Opthea Limited released FY2024 Annual Earnings on September 15, 2025, EST: Actual Revenue USD 262K (Forecast USD 516.1K), Actual EPS USD -2.7607

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2025 9 Months earnings on September 15, 2025 (EST), with actual revenue of USD 156.02K and actual EPS of USD -0.9667

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2025 Annual Earnings on September 15 (EST), actual revenue USD 146K (forecast USD 207.33K), actual EPS USD -1.0633

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2025 Q2 earnings on February 27, 2025 (EST) with actual revenue of USD 74.5K and EPS of USD -0.4328

Opthea Limited released FY2025 semi-annual earnings on February 27 (EST), actual revenue USD 157.62 K (forecast USD 94.89 K), actual EPS USD -0.8669

Opthea Limited released FY2024 Semi-Annual Earnings on February 27, 2025 (EST), with actual revenue of USD 202K (forecast USD 24.76K) and actual EPS of USD -1.3744

Opthea Limited released FY2024 Q1 earnings on February 27, 2025 (EST), with actual revenue of USD 101K and EPS of USD -0.6872

Opthea Limited released FY2024 Q2 earnings on February 27, 2025 (EST), with actual revenue of USD 101K and EPS of USD -0.6872

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS released FY2025 Q1 earnings on February 27, 2025 (EST) with actual revenue of USD 82.87K and EPS of USD -0.4557

Skillz

Euda Health

Trio-Tech Int

Pineapple Financial

Dreamland

Direxion Daily TXN Bull 2X ETF

System1

NewcelX

Amesite

TAILWIND 2.0 ACQUISITION CORP ORD USD0.0001 CL A (S/R)07/11/2030

Kiniksa Pharmaceuticals

Rigel Pharma

MiMedx

CapForce Inc.

OpGen

Vertex Pharma

Regeneron Pharma

Argenx

Alnylam Pharma

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS(OPTEY.US)

OPTHEA LIMITED SPON ADR EACH REP 8 ORD SHS Stock Performance Chart